A B S T R A C T This report examined the effect of corticosteroids in vitro on human peripheral blood monocytes, essential cells in both immune and nonimmune cellular defense mechanisms. Monocyte chemotaxis in response to sera, Escherichia coli filtrate, and lymphokine chemotactic factor was markedly reduced (P < 0.01) by hydrocortisone succinate (HCS) at 16 Ag/ml. Methylprednisolone succinate and unesterified hydrocortisone produced similar impairment of monocyte chemotaxis while two drugs which unmodified do not enter cells, hydrocortisone phosphate (HCP) and cortisone acetate, had no effect on chemotaxis. HCS also significantly impaired monocyte random migration at 16 jug/ml. Monocyte bactericidal activity was reduced by HCS at 16 Ag/ml (P < 0.01) ) but was not affected by HCP even at 120 Lg/ml. In comparison, HCS did not alter granulocyte chemotaxis even at 500 Ag/ml, and bactericidal activity was reduced at 16 jg/ml (P < 0.01). Monocyte phagocytosis of cryptococci was reduced only 20% (P < 0.05) at 120 Ag/ml. HCS at 120 Ag/ml did not alter monocyte base-line or postphagocytic hexosemonophosphate shunt activity, viability by trypan blue exclusion, adherence to tissue culture flasks, or surface binding of IgG globulin. These corticosteroid-induced defects in monocyte function may contribute to reduced cellular defense during corticosteroid therapy.
INTRODUCTION
Corticosteroid therapy is thought to interfere with cellular immunity in man since recipients have an increased incidence of granulomatous infections (1, 2) and reduced delayed hypersensitivity reactions (3) . The cellular immune response involves the participation of two This work has in part been published in abstract form. 1973 . Clin Received for publication 8 April 1974 and in revised form 30 July 1974. major cell types, the lymphocyte and the monocytemacrophage. Although a number of studies indicate that corticosteroids induce a deficit in human lymphocyte number and function (4) (5) (6) , no studies have examined the effects of corticosteroids on monocyte function in man.
Studies in experimental animals suggest that the function of the monocyte-macrophage system may be seriously impaired by corticosteroids. Weston, Mandel, Yeckley, Kruegers, and Claman found that lymphocytes from corticosteroid-treated guinea pigs immunized with tuberculin had a normal capacity to passively transfer tuberculin reactivity to normal guinea pigs. In contrast, corticosteroids impaired skin reactivity to tuberculin in guinea pigs receiving lymphocytes from donors with strong tuberculin immunity (7) . In vitro experiments suggest that one aspect of this defective macrophage function may be related to interference with normal macrophage response to lymphocyte products thought to mediate the cellular immune reaction (lymphokines). These studies demonstrated that corticosteroids interfered with the effects of migration inhibition factor and macrophage aggregating factor on guinea pig macrophages (8, 9) . Further, North has shown that corticosteroids can inhibit macrophage but not granulocyte exudation in rabbits (10) .
These observations suggest that monocyte-macrophage defects may contribute to the adverse effects of corticosteroids on cellular defenses. This report de- scribes the in vitro effects of corticosteroids on a variety of assays of human monocyte function.
METHODS
Cells. Mononuclear cells were isolated by Ficoll-Hypaque separation of blood from normal volunteers as previously described (11) . These preparations contained 20- 30% monocytes and 70-80% lymphocytes. Blood leukocytes were obtained by dextran sedimentation (12) and contained 70-80% granulocytes. Immediately before functional assays, corticosteroids were added to cell suspensions. Cell viability was determined by trypan blue exclusion.
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Chemotaxis. The chemotactic responsiveness of whole blood leukocytes or mononuclear cells was determined by the method of Snyderman, Altman, Hausman, and Mergenbagen (13) . Mononuclear preparations were suspended to 5 X 106 cells/ml in Gey's balanced salt solution (GBSS) 1 (pH 7.1) containing various concentrations of corticosteroids. 1 ml of cell suspension was allowed to migrate across 5-um Nucleopore filters (Nucleopore Corp., Pleasanton, Calif.) at 37°C for 90 min. Granulocyte chemotaxis was performed under identical conditions except that 3.5 X 106 cells/ml of whole blood leukocytes were used. Various chemotactic stimuli were used including heatinactivated sera (14) , Eschcrichia coli filtrate (15) , and the supernate of antigen (tuberculin)-stimulated lymphocyte cultures containing chemotactic factor (13) . For assay of random movement, no chemotactic stimulus was used and chambers were incubated 4 h. Results were expressed as mean number of cells/high-power field (hpf) for heat-inactivated sera, and E. coli filtrate. Because it represents a relatively weak stimulus, results obtained by using chemotactic factor were expressed as mean number of cells/5 hpf. The data in some experiments were also expressed as percent inhibition of chemotaxis as compared to a non-corticosteroid-treated control.
Bactericidal assay. Bactericidal activity was determined by the method of Root, Rosenthal, and Balestra (16) Glucose metabolism. Platelet-free monocyte monolayers of 95% purity were formed as previously described (17) in glass metabolic flasks. '4CO2 production from [1-"C]glucose was monitored continuously in an ionization chamber-electrometer apparatus (18) . Base-line "4CO2 production of the monolayers was quantitated and the effect of phagocytosis of latex particles determined by addition of 0. More importantly, the chemotactic assay system was modified to allow examination of the effect of HCS on monocyte chemotaxis in the absence of lymphocytes. For these studies, 5 X 106 mononuclear cells were placed in the upper portion of the chemotactic chamber without any material in the lower chamber. After 2 h incubation at 370C, the upper chamber was washed rigorously with GBSS to remove nonadherent lymphocytes leaving a monocyte monolayer on the Nuclepore filter (> 95% monocytes by morphologic criteria). 1 ml of GBSS containing 0, 16, or 120 Ag was preincubated with the monocyte monolayer for 30 min, and then the chemotactic stimuli (E. coli filtrate) was placed in the lower chamber and the assay completed in the usual fashion. The mean and standard error for the inhibition of chemotaxis in three experiments by 16 *g and 120 /Lg HCS was 62±16 and 95+2, respectively. Thus, the inhibition of monocyte chemotaxis by HCS is not dependent on the presence of lymphocytes.
To determine if HCS reduced chemotaxis by binding or inactivating chemotactic substances, HCS was added to the lower chamber with E. coli filtrates rather than to the upper chamber with the mononuclear suspension. No significant reduction in chemotaxis was observed at 16 or 120 /Ag/ml HCS (Table I ). The lack of direct s/g/ml (P < 0.01).
effect of HCS on monocytes in this experiment is probably due to the poor diffusion of HCS across the filter in this nonagitated, short incubation (90 min) system. Random movement of monocytes was significantly reduced by HCS at 16 tg/ml (P < 0.05) and 120 /Ag/ml (P <0.01) in duplicate experiments (Table II) . HCS was not itself chemotactic at either 16 or 120 ,ig/ml. To determine if the chemical structure of the corticosteroid modified this adverse effect, the chemotactic response of E. coli filtrate was studied with a variety of cortisone preparations (Fig. 3) . Hydrocortisone phosphate and cortisone acetate, which unmodified are unable to cross cell membranes (22) Fig. 4 .
Effect of corticosteroids on bactericidal activity. HCS produced significant depression of monocyte bactericidal activity at 16 ig/ml or greater (Fig. 5) (23) . As depicted in Fig. 6 , 120 Ag/ml of HCS did not impair either base-line or postphagocytic 'CO2 production from [1-14C] glucose, reflecting an intact HMP shunt response to this maximal stimulus.
Effect of corticosteroids on phagocytic function. Although the normal metabolic response of monocytes after latex ingestion would suggest an intact phagocytic capacity in the presence of 120 Ig/ml HCS, this assay is done in a vast excess of latex particles and is not a sensitive measure of phagocytic activity. We, therefore, examined the effect of HCS on monocyte cryptococcal phagocytosis. In three experiments, HCS at 16 t'g/ml had no adverse effect while at 120 i&g/ml a modest 20% reduction in phagocytosis was noted. This represented a decrease in cryptococci ingested/i4g monocyte DNA from 21.4±1.0 X 104 to 14.9±1.5 X 10' (P < 0.05).
Effect of corticosteroids on monocyte membrane function. We have previously noted that monocyte binding of IgG-coated red cells is not dependent on intracellular metabolic activity but is adversely effected by chemical modification of the cell membrane (21) . HCS did not alter monocyte binding of IgG globulin-coated RBC in two experiments. RBC bound/monolayer were 12.6±1.5 X 105 and 16.5±-3.7 X 10' in the absence of HCS and 17.1±1.6 X 10' and 17.0±1.3 X 10' in the presence of 120 Ag/ml HCS.
We also examined the effects of HCS on monocyte adherence to plastic tissue culture dishes. In three experiments, HCS in concentrations of 16 I.g/ml and 120 /Lg/ml did not alter the number of monocytes able to adhere to the tissue culture dishes in a 2-h period. Also, HCS in concentrations as high as 1,000 ig/ml did not alter monocyte viability as judged by trypan blue exclusion.
DISCUSSION
These studies indicate that blood monocytes have a unique in vitro sensitivity to corticosteroids. They have impaired random movement, chemotaxis, and bactericidal activity after only brief periods (60-90 min) of contact with concentrations of HCS as low as 16 Ag/ ml. Similar concentrations have been reached in vivo with administration of 100-500 mg of HCS and methylprednisolone succinate (24, 25) . In contrast, granulocyte migration and chemotaxis was not effected by HCS concentrations as high as 500 /Lg/ml as previously reported (26) . Granulocyte bactericidal activity, however, was impaired by low doses of HCS in the present study, while Mandell, Rubin, and Hook (27) showed consistent impairment only at high concentrations (1, 200 /%g/ml) of HCS. The explanation for this lack of agreement of the effect of HCS on granulocyte bactericidal activity is unclear although a number of differences exist in the methodology utilized in these studies.
These observations suggest that defective monocyte function may contribute to impaired cellular immune resistance in patients receiving corticosteroids. The blood monocyte represents the circulating cell which responds to chemotactic stimuli and matures to a tissue macrophage at sites of infection or inflammation (28) . The chemotactic stimuli may represent products of immune lymphocytes (lymphokines) or products of the infectious agent themselves. The observation in this study that HCS interferes with the monocyte response to both of these types of chemotactic stimuli suggests that this effect on chemotaxis may account at least in part for impaired macrophage exudation (10) and poor delayed hypersensitivity skin test reactions (3, 7) observed in vivo. Once at the site of reaction, macrophages are called upon to ingest and kill intracellular organisms (28) and may exert tumorcidal activity (29) . Our studies indicate interference by HCS of the bactericidal process, and a study by Hibbs has demonstrated interference of macrophage tumorcidal activity in vitro with similar concentrations of HCS (30) . Thus, corticosteroid interference of monocyte-macrophage killing activities may further contribute to in vivo impairment of cellular defense mechanisms. These observations on chemotaxis and bactericidal activity of monocytes represent effects of corticosteroids in vitro and may not be operational in vivo. Preliminary studies in our laboratory, however, indicate that corticosteroids can also produce defects in monocyte function in vivo (31) .
The mechanisms involved in corticosteroid impairment of monocyte-macrophage function are unclear, but observations made in this report shed some light on this problem. The lack of adverse effect with corticosteroid preparations previously demonstrated to be unable to pass across cell membranes suggests that the inhibitory action is an intracellular event and not a surface phenomena. Corticosteroids apparently are not toxic to monocytes since these drugs did not effect glass adherence, resting or stimulated HMP shunt activity, or trypan blue exclusion, all of which are parameters of cell viability.
Chemotaxis represents a complicated and only partially defined process of surface and intracellular events. A cell-surface receptor is thought to bind or interact with the chemotactic agent and trigger a series of intracellular activities in which alignment of microfilaments and microtubules allow directional cell migration (32) (33) (34) (8, 9) . The observation that random migration is similarly inhibited, however, might indicate intereference with a basic mechanism involved in cell migration. This could well be due to an abnormality in microfilament or microtubule function. Cytochalasin B which totally disrupts microfilament function is a potent inhibitor of chemotaxis (34) . This gross distortion of microfilament function, however, also prevents cell adherence to cell surfaces and phagocytosis (35) , effects which were not seen with corticosteroids. Corticosteroids might influence some other, as yet undefined, component in cell migration.
In vitro bactericidal activity represents a sequence of events including membrane binding of antibody-complement-coated bacteria, ingestion, and intracellular killing. The presence of normal monocyte binding of IgGcoated red cells and lack of inhibition of latex and cryptococcal phagocytosis at low doses of HCS suggest that membrane binding and ingestion are not seriously affected. Intracellular killing of bacteria requires lysosomal migration to and fusion with bacteria containing phagosomes (36) . A sequence of metabolic events is associated with this event including the enzymatic generation of peroxide and stimulation of the HMP shunt (37) . The observation that HCS did not prevent stimulation of HMP shunt activity of monocytes after ingestion of latex particles suggests that the metabolic pathways involved in peroxide generation and HMP shunt response are not directly inhibited. The microfilament-microtubule systems in phagocytic cells are thought to play a role in lysosomal migration to phagosomes (38) . Also, corticosteroids appear to "stabilize" lysosomes (39) which may prevent their fusion with the phagosome. Recent studies by Hibbs (30) have demonstrated that HCS in similar concentrations and under similar experimental conditions can interefere with lysosomal exocytosis in activated murine peritoneal macrophages. Whether the effect of corticosteroids in this study is due to impairment of lysosomal function or an effect on a crucial intracellular enzymatic or metabolic activity is unclear but represents a fertile area of future investigation.
